A Division of National Health Laboratory Services, National Institute for Occupational Health, Johannesburg, South Africa.
Haematology and Molecular Medicine Department, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
PLoS One. 2021 Dec 7;16(12):e0260207. doi: 10.1371/journal.pone.0260207. eCollection 2021.
Genetic molecular studies used to understand potential risks of engineered nanomaterials (ENMs) are incomplete. Intracellular residual ENMs present in biological samples may cause assay interference. This report applies the high-resolution melt (HRM) feature of RT-qPCR to detect shifts caused by the presence of gold nanoparticles (AuNPs). A universal RNA standard (untreated control) sample was spiked with known amounts of AuNPs and reverse transcribed, where 10 reference genes were amplified. The amplification plots, dissociation assay (melt) profiles, electrophoretic profiles and HRM difference curves were analysed and detected interference caused by AuNPs, which differed according to the amount of AuNP present (i.e. semi-quantitative). Whether or not the assay interference was specific to the reverse transcription or the PCR amplification step was tested. The study was extended to a target gene-of-interest (GOI), Caspase 7. Also, the effect on in vitro cellular samples was assessed (for reference genes and Caspase 7). This method can screen for the presence of AuNPs in RNA samples, which were isolated from biological material in contact with the nanomaterials, i.e., during exposure and risk assessment studies. This is an important quality control procedure to be implemented when quantifying the expression of a GOI from samples that have been in contact with various ENMs. It is recommended to further examine 18S, PPIA and TBP since these were the most reliable for detecting shifts in the difference curves, irrespective of the source of the RNA, or, the point at which the different AuNPs interacted with the assay.
用于了解工程纳米材料(ENMs)潜在风险的遗传分子研究并不完善。生物样本中存在的细胞内残留的 ENMs 可能会引起检测干扰。本报告应用 RT-qPCR 的高分辨率熔解(HRM)特性来检测金纳米粒子(AuNPs)存在引起的变化。将通用 RNA 标准(未经处理的对照)样品与已知量的 AuNPs 混合并进行逆转录,其中扩增了 10 个参考基因。分析和检测了扩增图谱、解链测定(熔解)图谱、电泳图谱和 HRM 差异曲线,以及由 AuNPs 引起的干扰,其干扰程度取决于 AuNP 的含量(即半定量)。测试了是否存在针对逆转录或 PCR 扩增步骤的检测干扰特异性。该研究扩展到了感兴趣的靶基因(GOI) Caspase 7。此外,还评估了对体外细胞样品的影响(针对参考基因和 Caspase 7)。该方法可用于筛选与纳米材料接触的生物材料中分离出的 RNA 样品中 AuNPs 的存在,例如在暴露和风险评估研究期间。这是一种重要的质量控制程序,用于从与各种 ENMs 接触的样品中定量表达 GOI 时实施。建议进一步检查 18S、PPIA 和 TBP,因为无论 RNA 的来源或不同的 AuNPs 与检测相互作用的时间点如何,这些基因在差异曲线中检测到变化时最可靠。